NEW YORK (GenomeWeb News) — Affymetrix late yesterday said that third-quarter revenue rose 12 percent as R&D spending declined 24 percent and last year’s loss swung to a profit.

Total revenue for the three months ended Sept. 30 increased to $95 million from $84.7 million year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.